Interasma Global Asthma Association

All posts by Juan Carlos Ivancevich

Economic burden of short-acting beta-2 agonist (SABA) overuse among asthma patients in Türkiye: a cost analysis with respect to the updated GINA treatment recommendations

Yorgancıoğlu, A., Aksu, K., Cura, C. et al. BMC Pulm Med 24, 524 (2024). https://doi.org/10.1186/s12890-024-03327-9 Abstract Background This cost of illness study aimed to determine economic burden of short-acting β2-agonist (SABA) overuse in…